Abstract
Preimplantation genetic testing-human leukocyte antigen ‘(PGT-HLA) only’ refers to the HLA typing of single or few cells biopsied from in vitro fertilized preimplantation embryos. The aim of the procedure is to establish a pregnancy, in which the fetus is HLA compatible with an affected sibling in need of a hematopoietic stem cell transplantation (HSCT). During PGT-M-HLA, the identification of a HLA-compatible embryo is combined with the detection of mutation(s) underlying immunodeficiencies and hemoglobinopathies. We report a combined retrospective and prospective cohort analysis of PGT-(M-)HLA procedures carried out from 1998 until 2017, with follow-up of transplantations to 2019. During the study period, 234 couples from 22 countries were invited for a multidisciplinary consultation. Two couples were rejected and 70 couples declined (various reasons), leaving 162 couples for which 414 clinical cycles were carried out. Cleavage stage biopsy followed by single-cell multiplex PCR for short tandem repeat-based haplotyping was applied in most cases (98.7%). The diagnostic efficiency was high (94.8%) but only 16.5% of the embryos was genetically suitable for transfer. Fresh and frozen-thawed embryo transfer resulted in 67 clinical pregnancies, 63 deliveries, and 74 live births, of which 60 children were HLA compatible. This yielded a live birth delivery rate of 30.3% per transfer. Information on neonatal characteristics of the matching PGT-(M-)HLA children showed reassuring outcomes. So far, HSCT was carried out successfully for 25 out of 26 cases. In conclusion, our data show that PGT-(M-)HLA is a valuable procedure: the high complexity and limited delivery rate are balanced by the successful HSCT outcome and the positive impact on families.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Yeşilipek MA. Hematopoetic stem cell transplantation in children. Turk Pediatr Ars. 2014;49:91–8.
Verlinsky Y, Rechitsky S, Schoolcraft W, Strom C, Kuliev A. Preimplantation diagnosis for Fanconi anemia combined with HLA matching. JAMA. 2001;285:3130–3.
De Rycke M, Van de Velde H, Sermon K, Lissens W, De Vos A, Vandervorst M. Preimplantation genetic diagnosis for sickle-cell anemia and for beta-thalassemia. Prenat Diagn. 2001;21:214–22.
Van Steirteghem A, Nagy Z, Liu J, Joris H, Verheyen G, Smitz J. Intracytoplasmic sperm injection. Baillieres Clin Obstet Gynaecol. 1994;8:85–93.
Vandervorst M, Liebaers I, Sermon K, Staessen C, De Vos A, Van de Velde H. Successful preimplantation genetic diagnosis is related to the number of available cumulus-oocyte complexes. Hum Reprod. 1998;13:3169–76.
Pennings G, Schots R, Liebaers I. Ethical considerations on preimplantation genetic diagnosis for HLA typing to match a future child as a donor of haematopoietic stem cells to a sibling. Hum Reprod. 2002;17:534–8.
Belgian Law of July 6, 2007 on medically assisted reproduction. Beschikbaar op: http://www.ejustice.just.fgov.be/eli/wet/2007/07/06/2007023090/justel. Geciteerd 20 mei 2019.
Baetens P, Van de Velde H, Camus M, Pennings G, van Steirteghem A, Devroey P. HLA-matched embryos selected for siblings requiring haematopoietic stem cell transplantation: a psychological perspective. Reprod Biomed Online. 2005;10:154–63.
Van de Velde H, Georgiou I, De Rycke M, Schots R, Sermon K, Lissens W. Novel universal approach for preimplantation genetic diagnosis of beta-thalassaemia in combination with HLA matching of embryos. Hum Reprod. 2004;19:700–8.
Kakourou G, Kahraman S, Ekmekci GC, Tac HA, Kourlaba G, Kourkouni E. The clinical utility of PGD with HLA matching: a collaborative multi-centre ESHRE study. Hum Reprod. 2018;33:520–30.
Kahraman S, Beyazyurek C, Yesilipek MA, Ozturk G, Ertem M, Anak S. Successful haematopoietic stem cell transplantation in 44 children from healthy siblings conceived after preimplantation HLA matching. Reprod Biomed Online. 2014;29:340–51.
Bonduelle M, Wilikens A, Buysse A, Van Assche E, Devroey P, Van Steirteghem AC. A follow-up study of children born after intracytoplasmic sperm injection (ICSI) with epididymal and testicular spermatozoa and after replacement of cryopreserved embryos obtained after ICSI. Hum Reprod. 1998;13(Suppl 1):196–207.
Van de Velde H, De Rycke M, De Man C, De Hauwere K, Fiorentino F, Kahraman S. The experience of two European preimplantation genetic diagnosis centres on human leukocyte antigen typing. Hum Reprod. 2009;24(maart):732–40.
Shenfield F, Pennings G, Cohen J, Devroey P, Tarlatzis B. ESHRE Task Force on Ethics and Law. Taskforce 9: the application of preimplantation genetic diagnosis for human leukocyte antigen typing of embryos. Hum Reprod. 2005;20:845–7.
Nekkebroeck J, Rigo A, Desmyttere S, Bonduelle M, Liebaers I. PGD for HLA matching preliminary psychological child outcome. Hum Reprod. 2009;24:i236–56.
Handyside AH, Harton GL, Mariani B, Thornhill AR, Affara N, Shaw, et al. Karyomapping: a universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes. J Med Genet. 2010;47:651–8.
Natesan SA, Bladon AJ, Coskun S, Qubbaj W, Prates R, Munne S. Genome-wide karyomapping accurately identifies the inheritance of single-gene defects in human preimplantation embryos in vitro. Genet Med. 2014;16:838–45.
Reichenbach J, Van de Velde H, De Rycke M, Staessen C, Platteau P, Baetens P. First successful bone marrow transplantation for X-linked chronic granulomatous disease by using preimplantation female gender typing and HLA matching. Pediatrics. 2008;122:e778–82.
Harton GL, De Rycke M, Fiorentino F, Moutou C, SenGupta S, Traeger-Synodinos J. ESHRE PGD consortium best practice guidelines for amplification-based PGD. Hum Reprod. 2011;26:33–40.
Fiorentino F, Magli MC, Podini D, Ferraretti AP, Nuccitelli A, Vitale N. The minisequencing method: an alternative strategy for preimplantation genetic diagnosis of single gene disorders. Mol Hum Reprod. 2003;9:399–410.
Verpoest W, De Vos A, De Rycke M, Parikh S, Staessen C, Tournaye H. Gonadotropin releasing hormone agonists or antagonists for preimplantation genetic diagnosis (PGD)? A prospective randomised trial. Curr Pharm Biotechnol. 2017;18:622–7.
Gardner DK, Schoolcraft WB. Culture and transfer of human blastocysts. Curr Opin Obstet Gynecol. 1999;11:307–11.
Van den Abbeel E, Camus M, Verheyen G, Van Waesberghe L, Devroey P, Van Steirteghem A. Slow controlled-rate freezing of sequentially cultured human blastocysts: an evaluation of two freezing strategies. Hum Reprod. 2005;20:2939–45.
Van Landuyt L, Polyzos NP, De Munck N, Blockeel C, Van de Velde H, Verheyen G. A prospective randomized controlled trial investigating the effect of artificial shrinkage (collapse) on the implantation potential of vitrified blastocysts. Hum Reprod. 2015;30:2509–18.
Kolibianakis EM, Zikopoulos K, Verpoest W, Camus M, Joris H, Van Steirteghem AC. Should we advise patients undergoing IVF to start a cycle leading to a day 3 or a day 5 transfer? Hum Reprod. 2004;19:2550–4.
Van Landuyt L, Stoop D, Verheyen G, Verpoest W, Camus M, Van, et al. Outcome of closed blastocyst vitrification in relation to blastocyst quality: evaluation of 759 warming cycles in a single-embryo transfer policy. Hum Reprod. 2011;26:527–34.
Kolibianakis EM, Zikopoulos K, Devroey P. Implantation potential and clinical impact of cryopreservation-a review. Placenta. 2003;24(suppl B):S27–33.
Peffault de Latour R, Chevret S, Jubert C, Sirvent A, Galambrun C, Ruggeri A. Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study. Blood. 2018;132:750–4.
De Rycke M, Goossens V, Kokkali G, Meijer-Hoogeveen M, Coonen E, Moutou C, et al. Consortium data collection XIV-XV: cycles from January 2011 to December 2012 with pregnancy follow-up to October 2013. Hum Reprod. 2017;32:1974–94.
Berckmoes V, Verdyck P, De Becker P, De Vos A, Verheyen G, Van, et al. Factors influencing the clinical outcome of preimplantation genetic testing for polycystic kidney disease. Hum Reprod. 2019;34(mei):949–58.
Goossens V, De Rycke M, De Vos A, Staessen C, Michiels A, Verpoest W. Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis. Hum Reprod. 2008;23:481–92.
De Vos A, Staessen C, De Rycke M, Verpoest W, Haentjens P, Devroey P. Impact of cleavage-stage embryo biopsy in view of PGD on human blastocyst implantation: a prospective cohort of single embryo transfers. Hum Reprod. 2009;24:2988–96.
De Rycke M, Belva F, Goossens V, Moutou C, SenGupta SB, Traeger-Synodinos J, et al. ESHRE PGD Consortium data collection XIII: cycles from January to December 2010 with pregnancy follow-up to October 2011. Hum Reprod. 2015;30:1763–89.
Rechitsky S, Pakhalchuk T, San Ramos G, Goodman A, Zlatopolsky Z, Kuliev A. First systematic experience of preimplantation genetic diagnosis for single-gene disorders, and/or preimplantation human leukocyte antigen typing, combined with 24-chromosome aneuploidy testing. Fertil Steril. 2015;103:503–12.
Desmyttere S, De Rycke M, Staessen C, Liebaers I, De Schrijver F, Verpoest W. Neonatal follow-up of 995 consecutively born children after embryo biopsy for PGD. Hum Reprod. 2012;27:288–93.
Williams TN, Thein SL. Sickle cell anemia and its phenotypes. Annu Rev Genomics Hum Genet. 2018;19:113–47.
Kurekci E, Küpesiz A, Anak S, Öztürk G, Gürsel O, Aksoylar S. Hematopoietic stem cell transplantation using preimplantation genetic diagnosis and human leukocyte antigen typing for human leukocyte antigen-matched sibling donor: a Turkish multicenter study. Biol Blood Marrow Transpl. 2017;23:790–4.
Acknowledgements
We wish to thank the clinical, paramedical, and laboratory teams of the Center for Medical Genetics and the Center for Reproductive Medicine of the Universitair Ziekenhuis Brussel. We also would like to thank the clinicians for referring the couples and the couples who participated in the study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
De Rycke, M., De Vos, A., Belva, F. et al. Preimplantation genetic testing with HLA matching: from counseling to birth and beyond. J Hum Genet 65, 445–454 (2020). https://doi.org/10.1038/s10038-020-0732-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s10038-020-0732-z
This article is cited by
-
Cleavage-stage or blastocyst-stage embryo biopsy has no impact on growth and health in children up to 2 years of age
Reproductive Biology and Endocrinology (2023)
-
Genetic Counseling and Family Screening Recommendations in Patients with Telomere Biology Disorders
Current Hematologic Malignancy Reports (2023)